Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial

This publication has 23 references indexed in Scilit:

• EUCAST Technical Note on tigecycline
  Clinical Microbiology & Infection, 2006
• Antibiotic Coresistance in Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae and In Vitro Activity of Tigecycline
  Antimicrobial Agents and Chemotherapy, 2006
• In Vitro Activity of Tigecycline against Isolates from Patients Enrolled in Phase 3 Clinical Trials of Treatment for Complicated Skin and Skin‐Structure Infections and Complicated Intra‐Abdominal Infections
  Clinical Infectious Diseases, 2005
• Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit
  Diagnostic Microbiology and Infectious Disease, 2005
• Surveillance and epidemiology of MRSA bacteraemia in the UK
  Journal of Antimicrobial Chemotherapy, 2005
• Trends in Antimicrobial Drug Development: Implications for the Future
  Clinical Infectious Diseases, 2004
• The Glycylcyclines
  Drugs, 2004
• Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial Isolates
  Antimicrobial Agents and Chemotherapy, 2003
• In Vitro Activities of Tigecycline (GAR-936) against Recently Isolated Clinical Bacteria in Spain
  Antimicrobial Agents and Chemotherapy, 2002
• In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum β-lactamases
  Diagnostic Microbiology and Infectious Disease, 2001